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Abstract
Objective: FOXG1 syndrome is a rare neurodevelopmental disorder associated
with heterozygous FOXG1 variants or chromosomal microaberrations in 14q12.
The study aimed at assessing the scope of structural cerebral anomalies revealed
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by neuroimaging to delineate the genotype and neuroimaging phenotype associ-
ations. Methods: We compiled 34 patients with a heterozygous (likely) patho-
genic FOXG1 variant. Qualitative assessment of cerebral anomalies was
performed by standardized re-analysis of all 34 MRI data sets. Statistical analysis
of genetic, clinical and neuroimaging data were performed. We quantified clinical
and neuroimaging phenotypes using severity scores. Telencephalic phenotypes of
adult Foxg1+/ mice were examined using immunohistological stainings fol-
lowed by quantitative evaluation of structural anomalies. Results: Characteristic
neuroimaging features included corpus callosum anomalies (82%), thickening of
the fornix (74%), simplified gyral pattern (56%), enlargement of inner CSF spaces
(44%), hypoplasia of basal ganglia (38%), and hypoplasia of frontal lobes (29%).
We observed a marked, filiform thinning of the rostrum as recurrent highly typi-
cal pattern of corpus callosum anomaly in combination with distinct thickening
of the fornix as a characteristic feature. Thickening of the fornices was not
reported previously in FOXG1 syndrome. Simplified gyral pattern occurred sig-
nificantly more frequently in patients with early truncating variants. Higher clini-
cal severity scores were significantly associated with higher neuroimaging severity
scores. Modeling of Foxg1 heterozygosity in mouse brain recapitulated the associ-
ated abnormal cerebral morphology phenotypes, including the striking enlarge-
ment of the fornix. Interpretation: Combination of specific corpus callosum
anomalies with simplified gyral pattern and hyperplasia of the fornices is highly
characteristic for FOXG1 syndrome.
Introduction
FOXG1 syndrome (OMIM #613454), initially designated
“congenital variant of Rett syndrome”, is a rare neurodevel-
opmental disorder associated with heterozygous variants in
the forkhead box G1 (FOXG1) gene or chromosomal
microaberrations in 14q12 involving FOXG1.1–3 The
genetic and phenotypic spectrum is expanding.4–8 In con-
trast to classical Rett syndrome with consistently normal
neuroimaging, cerebral malformations were shown to be
part of the phenotype of FOXG1 syndrome. Previous case
reports and small case series described gyral simplification/
simplified gyral pattern, enlarged lateral ventricles, dimin-
ished white matter volume in the frontal lobes, corpus cal-
losum anomalies, and mild frontal pachygyria.3,8–14
This study aimed at a more detailed assessment of the
structural brain anomalies in FOXG1 syndrome as revealed
by cerebral MRI, based on a standardized analysis of a large
series (n = 34) of MRI data sets by a single team of investi-
gators. Furthermore, we searched for associations between
genotype and neuroimaging phenotype as well as associa-
tions between clinical and neuroimaging phenotype.
A mouse model was used to reproduce the effect of
heterozygous loss of Foxg1 function on the development
of telencephalic structures15 using immunohistological
stainings followed by quantitative evaluation of various
attendant structural anomalies.
Patients and methods
Using an email based acquisition of rare neurological disor-
ders in childhood (“Erhebung Seltener Neurologischer
Erkrankungen im Kindesalter, ESNEK”)16 and in an ongo-
ing collaboration with pediatric neurologists, neuroradiolo-
gists and human geneticists from Germany, Switzerland,
and the United States we compiled data from 10 new and
24 previously reported7 patients with a heterozygous
FOXG1 variant. We recruited patients between February
2015 and September 2017.
Inclusion criteria for this study comprised (1) patho-
genic or likely pathogenic intragenic FOXG1 variant
according to the recommendations for interpretation of
sequence variants published by the American College of
Medical Genetics and Genomics (ACMG)17, (2) availabil-
ity of cranial MRI data sets, and (3) written informed
consent from the parents or legal guardians.
We excluded patients with chromosomal microaberrations
in 14q12 involving additional genes adjacent to the FOXG1
gene. Thus we obviated impact of mutations in other genes
on clinical and neuroimaging features and avoided blurring
the borders of the FOXG1-associated phenotype.
Clinical data were generated by review of the clinical
histories and follow-up investigations. Missing data were
collected through telephone interview with the parents
using a standardized questionnaire.
656 ª 2019 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association.
Structural brain anomalies in FOXG1 syndrome M. Pringsheim et al.
This study was approved by the ethics committee of
the Faculty of Medicine, University of G€ottingen. Written
informed consent was obtained from all families.
Clinical phenotype
We roughly quantified the clinical phenotypes associated with
pathogenic FOXG1 variants in all 34 patients using a previously
reported FOXG1 severity score.7 This score was obtained by
averaging 17 phenotypic items in four categories: somatic
growth (4 items), motor and speech development (4 items, if
applicable according to patient0s age), behavior (3 items), and
neurological features (6 items) (Table 1).
Phenotypic items were rated on a 0 to 2-point scale,
with higher scores indicating a more severe clinical phe-
notype. We used the mean of these single item ratings
rather than the sum score, as several items related with
motor and speech development did not apply to patients
younger than two years.
Neuroimaging phenotype
All 34 MRI data sets were analyzed by two pediatric neurol-
ogists with experience in neuroimaging of neurodevelop-
mental disorders (MP, MS). They scrutinized all available
imaging sequences in axial, coronal, and sagittal orienta-
tion with focus on cortical malformations and gyral pat-
tern, morphology of corpus callosum and basal ganglia, as
well as cortical and subcortical volume (Fig. 1).
Based on previous descriptions in the literature3 and
the evolving evaluation of our MRI data sets we devel-
oped a new FOXG1 neuroimaging severity score
(Table 2). This score covered the following items: simpli-
fied gyral pattern, hypoplasia of basal ganglia, enlarge-
ment of inner CSF spaces, corpus callosum anomalies,
fornix anomalies, and hypoplasia of frontal lobes. These
items were rated each with 0 to 1 or 0 to 3 points,
depending on the respective item. Thus, completely nor-
mal MRI findings resulted in a score of 0 points, while a
maximum score of 8 points indicated the most severe
neuroimaging anomalies.
Delay of myelination, although observed in numerous
patients, was not included in this score, as it shows a
strong age dependency. Most patients with delayed myeli-
nation eventually reach a mature appearance, albeit later
than healthy controls. Therefore, when MRI is performed
later in life, this item would erroneously be scored as
“normal”.
Genotype
Molecular genetic data were compiled from former clini-
cal testing. As conducted previously by Mitter et al.7, we
divided the patients into five genetic subgroups according
to the type and location of their variant within the fol-
lowing five specific FOXG1 domains: (1) N-terminal
domain frameshift and nonsense variants (n = 16), (2)
forkhead domain conserved site 1 missense variants
(n = 8), (3) forkhead domain except conserved site 1 fra-
meshift and nonsense variants (n = 3), (4) forkhead
domain except conserved site 1 missense variants (n = 3),
and (5) C-terminal domain frameshift and nonsense vari-
ants (n = 4). This classification formed the basis for sta-
tistical analysis of genotype-phenotype associations.
Mouse model
Foxg1+/ mice18 were maintained in a C56BL/6 back-
ground. All mouse experiments were approved by the ani-
mal welfare committees of the University Medical Center
G€ottingen and local authority (LAVES: Nieders€achsisches
Landesamt f€ur Verbraucherschutz und Lebensmittelsicher-
heit) under the license numbers: 14/1636 and 16/2330.
Table 1. FOXG1 clinical severity score (adapted and modified from
Mitter et al.7)
Score
Clinical feature
Point
score 0
Point
score 1
Point
score 2
Somatic growth
Body length at last follow-up Normal <2 SD
BMI at last follow-up Normal <2 SD
Head circumference at birth Normal <2 SD
Head circumference at
last follow-up
Normal <2 SD
Motor development
Sitting (for patients
aged >12 months)
Unsupported Supported No
Walking (for patients
aged >24 months)
Unsupported Supported No
Functional hand use
(for patients aged
>12 months)
Yes No
Speech development
Expressive speech
(for patients aged
>24 months)
Yes No
Behavior
Social interaction Yes No
Eye contact Yes Poor No
Abnormal sleep patterns No Yes
Neurological features
Epilepsy No Yes
Spasticity No Yes
Stereotypic movements No Yes
Dyskinesia No Yes
Feeding difficulties No yes
Kyphoscoliosis/Scoliosis No Yes
Sum score min 0, max 34
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Figure 1. Spectrum of structural brain anomalies in FOXG1 syndrome revealed by neuroimaging. Gyral pattern: (A–E) T2-weighted axial MR images of
the fronto-parietal area in five patients with FOXG1 point mutations show (A, patient #17) normal gyral pattern; (B, #28) mild and (C, #32) moderate
simplified gyral pattern; as well as (D, #29; E, #24) simplified gyral pattern with dilated subarachnoid CSF spaces. Basal ganglia and fornices: (F–K) T2-
weighted axial MR images at the level of the basal ganglia show (F, #17) normal basal ganglia, (G, #6) small basal ganglia relative to thalamus, (H, #24; I,
#34) dilated ventricles, and (I, #34; K, #8) thickened fornices (arrows). Corpus callosum: (L, W) T1-weighted and (M through V) T2-weighted midsagittal
MR images show the spectrum of anomalies of the corpus callosum (CC), ranging from (L, #22) normal CC over various degrees (M, #2; N, #33; O, #17;
P, #15; Q, #6) of relative thinning of the anterior portions, (R, #18; S, #16) absent rostrum, (T, #8; U, #9; V, #34) partial agenesis of anterior parts to (W,
#1) almost complete agenesis. Note the characteristic elongation of the lamina terminalis stretching from the anterior end of the malformed CC to the
bottom of the third ventricle (white arrows in T). An anterior commissure is visible only in the milder variants (L–P; black arrows in O, P).
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Anesthesia and perfusion fixation
For immunohistochemical analysis of the adult mouse
brain, good tissue preservation is necessary. The com-
monly used postmortem immersion fixation is in many
cases not sufficient. For this purpose, tissue morphology
can be achieved by in vivo perfusion fixation with 4%
paraformaldehyde (PFA). The animals were under con-
stant anesthesia with  3% isoflurane. The anesthesia is
designed so that the animals do not wake up afterwards.
The fixans is administered intracardially in anesthetized
mice and transported directly via the vascular system.
Immunohistochemistry
Immunohistochemistry (IHC) was performed as previously
described.19,20 Briefly, brains from adult mice were perfused
with 4% PFA and incubated overnight in 30% sucrose.
Matched sections with 20 lm thickness from both wild
type and mutant brain were incubated overnight with pri-
mary antibodies: MBP (Cat. MAB386, Chemicon, dilution
1:100), DARPP32 (Cat. AB1656, Chemicon, dilution 1:100)
at 4°C after blocking with normal goat serum. Primary
antibodies were detected with a fluorescent secondary anti-
body (Alexa Fluor, 1:400; Invitrogen). Sections were later
counterstained with Vectashield mounting medium con-
taining DAPI (Vector laboratories) to label nuclei. Images
were acquired with standard Axio Imager M2 (Zeiss) fluo-
rescence microscopes. Images were further analyzed with
Adobe Photoshop and NeuroLucida/StereoInvestigator.
Relative quantification of mouse brain
structures and statistical analysis
Parameters of mouse brain size were measured and ana-
lyzed as described previously.21,22 Briefly, 20 lm thick
coronal sections collected from the rostral to caudal parts
(corresponding to the levels 1 to 4) of the fornix in adult
mutant and control brains (n = 4) were selected for the
cerebral phenotype analysis (Figs. 2 and 3). The
immunostained sections spanning the entire fornix struc-
ture in WT and Foxg1+/ forebrain and their images
were used for quantitative analyses (Figs. 2 and 3). Corti-
cal thickness (Cx) as well as the area of striatum (Str,
MBP+, DARPP32+), basal ganglia (BG, MBP+), fornix (F,
MBP+), and corpus callosum (CC, MBP+) were measured
and compared in brain section images of mutants and
controls using the NIH ImageJ software.
Statistical methods
Patient data were summarized by mean  standard devia-
tion as well as median (minimum, maximum) for continu-
ous variables, and by absolute and relative frequencies for
categorical variables. Binary variables were compared
between mutation groups using logistic regression, whereas
ordinal regression was used for corpus callosum anomaly
comparison. The clinical score was tested for differences
between the mutation groups using the nonparametric
Kruskal-Wallis-Test in case of several mutation groups and
using the Mann-Whitney-U test in case of two mutation
groups. The MRI severity score was tested for differences
between the mutation groups using one-way ANOVA in
case of several mutation groups and using the Student0s t-
test in case of two mutation groups.
The test for correlation was calculated based on the
nonparametric Kendall’s s.
Statistical analysis of the histological data was done
using Student’s t-test and related bar graphs are plotted
as mean  SEM. Details of statistical analysis for the his-
tological data are presented in Supplementary Table 1.
The significance level was set to a = 5%. All analyses
were performed within the statistical programming envi-
ronment R (version 3.4.4, www.r-project.org), using the
package ordinal to perform the ordinal regression.
Results
We compiled clinical and genetic data as well as MRI data
sets from 34 patients with intragenic heterozygous FOXG1
variants. This cohort comprised 16 male and 18 female indi-
viduals, with ages at last clinical follow-up ranging from
10 months to 17 years (mean 4 years 11 months) and ages
at MRI ranging from 2 months to 16 years (mean 2 years
3 months). Clinical, genetic, and neuroimaging features are
summarized in Table 3 and displayed in more detail in Sup-
plementary Table 2 (accessible for direct download).
Genotype analysis
Genetic and clinical features of patients 1–24 were previ-
ously described.7 Among the 10 new patients, the
Table 2. FOXG1 neuroimaging severity score
Score
MRI
feature
Point
score 0
Point
score 1
Point
score 2
Point
score 3
Simplified gyral pattern Absent Present
Basal ganglia Normal Hypoplasia
Inner CSF spaces Normal Enlarged
Corpus callosum Normal Thinning Partial
agenesis
Complete
agenesis
Fornix Normal Thickening
Frontal lobes Normal Hypoplasia
Sum score min = 0, max = 8
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heterozygous FOXG1 variant occurred de novo in eight
patients. In two patients with FOXG1 variants reported
previously, parents were not available for testing. There
were five novel variants. Detailed genetic features are
given in Table 3 and Supplementary Table 2 (accessible
for direct download).
Figure 2. Heterozygous deletion of Foxg1 causes abnormal brain morphology in mice. (A) Immunostaining of MBP and DAPI in coronal sections
at different levels (rostral-caudal) of wild type (WT) and mutant (Foxg1+/) adult (2.5 months) mouse brain to visualize cross-section of the entire
forebrain and white matter commissural structures like the corpus callosum and fornix (F). (B, C) Bar charts depicting summary of the quantitative
analysis of the area of the entire adult mouse telencephalon and fornix, respectively. The cerebral area is significantly reduced (B) while the fornix
is conspicuously expanded (C) in mutant brains as compared with controls. The fornix is consistently expanded across its entire structure from
rostral to caudal (level 1-4) (C). Values are presented as means  SEMs (**P < 0.01, ***P < 0.005). Experimental replicates (n) = 4; Scale bar:
100 lm.
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Neuroimaging features
Table 4 and Figure 1 display the results of standardized
qualitative analysis of the 34 MRI data sets. Characteris-
tic neuroimaging features - ranked by descending fre-
quency - included corpus callosum anomalies (82%),
thickening of the fornix (74%), simplified gyral pattern
(56%), enlargement of inner CSF spaces (44%), hypopla-
sia of basal ganglia (compared with the thalami) (38%),
and hypoplasia of frontal lobes (29%). Anomalies of the
corpus callosum comprised complete agenesis in one
patient, partial agenesis in 22 individuals, and thinning
in five patients.
We observed a marked, filiform thinning of the ros-
trum as recurrent highly typical pattern of corpus callo-
sum anomaly (Fig. 1L–W), in line with the findings of
Kort€um et al.3 In addition, we detected distinct thicken-
ing of the fornix (Fig. 1I and K) as a characteristic feature
Figure 3. Further discrete cerebral anomalies in Foxg1+/ mouse brain sections. (A) Immunostaining of MBP, DARPP32 and DAPI in coronal sections
of wild type (WT) and mutant (Foxg1+/) adult (2.5 months) mouse brain to visualize gray matter areas such as the Cortex (Cx) and basal ganglia
(BG) or Striatum (Str), and white matter commissural systems like the corpus callosum (CC) and fornix (F). (B–E) Bar charts showing summary of the
quantitative analysis of forebrain structure alterations in mutants (Foxg1+/) at various section levels (1-4) as compared with controls. The thickness
of the corpus callosum (B) and distinct cortical domains like the medial cortex (mCx) dorsal cortex (dCx), and lateral cortex (lCx) (C) are significantly
reduced in mutants. The areas of the BG (D) and Str (E) are significantly reduced in mutant telencephalon as compared with that of controls. Values
are presented as means  SEMs (*P < 0.05, **P < 0.01, ***P < 0.005). Experimental replicates (n) = 4; Scale bar: 100 lm.
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in our cohort – a finding which was not reported previ-
ously in FOXG1 syndrome and which is uncommon in
neurodevelopmental conditions.
MRI was normal in three patients, aged two (#17),
seven (#12), and 16 years (#22) at MRI. These patients
carry a missense variant in the forkhead domain con-
served site 1 (mutation group 2, #17), an in frame dele-
tion in the forkhead domain except conserved site 1
(mutation group 3, #12), and a frameshift variant in the
C-terminal domain (mutation group 5, #22).
Associations between genotype, clinical
phenotype and neuroimaging features
Statistical analysis (Table 4) revealed two significant asso-
ciations:
(1) simplified gyral pattern occurred significantly more
frequently in patients with pathogenic frameshift and
nonsense variants in the N-terminal domain (mutation
group 1) compared to patients with other variants (muta-
tion groups 2 to 5) (p = 0.008), and
(2) more severe clinical phenotypes as assessed by the
FOXG1 clinical severity score were significantly associated
with more severe neuroimaging anomalies ascertained by
the MRI severity score (Kendall’s rank correlation tau:
s = 0.27; P = 0.03) (Fig. 4).
Beyond that, no statistically significant associations
between genotype and neuroimaging phenotype were
found, possibly partially due to small case numbers in the
five different mutation groups. However, we found trends
for more frequent occurrence of certain neuroimaging
Table 3. Genetic features, clinical severity scores and MRI severity scores in 34 patients with FOXG1 syndrome.
Pt.
no.
No. in Mitter
et al.7 Sex
FOXG1 variant
cDNA level Protein level Coding effect
FOXG1
domain
Mutat.
group Agea
FOXG1
CSS
Age
MRI
MRI
SS*
1 1 M c.256delC p.Q86Rfs*106 Frameshift N-terminal 1 40 0.94 12 8
2 2 M c.214C>T p.Q72* Nonsense N-terminal 1 51 1.25 48 5
3 3 M c.406G>T p.E136* Nonsense N-terminal 1 33 1.44 7 5
4 4 F c.460dupG p.E154Gfs*301 Frameshift N-terminal 1 100 1.12 7 6
5 5 F c.385delG p.E129Sfs*63 Frameshift N-terminal 1 23 1.24 36 1
6 6 F c.460delG p.E154Rfs*38 Frameshift N-terminal 1 39 1.50 6 4
7 7 M c.460dupG p.E154Gfs*301 Frameshift N-terminal 1 72 1.38 12 4
8 8 F c.460dupG p.E154Gfs*301 Frameshift N-terminal 1 45 1.44 5 5
9 9 M c.460dupG p.E154Gfs*301 Frameshift N-terminal 1 61 1.29 12 7
10 10 F c.517G>T p.E173* Nonsense N-terminal 1 30 1.14 24 4
11 11 M c.543G>C p.K181N Missense Forkhead cs 2 82 0.24 60 5
12 13 F c.545C>A p.P182Q Missense Forkhead cs 2 85 0.71 24 0
13 14 M c.553A>T p.S185C Missense Forkhead cs 2 93 1.06 12 2
14 16 F c.561C>A p.N187K Missense Forkhead cs 2 62 1.60 12 4
15 18 F c.565C>T p.L189F Missense Forkhead cs 2 33 1.00 11 5
16 19 F c.581T>G p.l194S Missense Forkhead cs 2 72 1.25 10 5
17 20 F c.592_594delCCC p.P198del In frame del Forkhead 3 25 0.71 10 0
18 21 M c.609_616delGCTCAACG p.L204Hfs*248 Frameshift Forkhead 3 46 1.24 4 6
19 22 M c.624C>G p.Y208* Nonsense Forkhead 3 38 1.35 12 6
20 25 M c.974dupT p.L325Ffs*130 Frameshift C-terminal 5 89 0.81 12 2
21 26 F c.1082dupG p.L362Pfs*93 Frameshift C-terminal 5 31 1.29 12 4
22 27 F c.1141delG p.A381Pfs*4 Frameshift C-terminal 5 204 0.47 192 0
23 28 F c.755G>A p.G252D Missense Forkhead 4 192 1.47 192 1
24 29 F c.921C>G p.Y307* Nonsense C-terminal 5 33 1.29 6 6
25 - M c.561C>G p.N187K Missense Forkhead cs 2 68 1.18 2 3
26 - F c.460dupG p.E154Gfs*301 Frameshift N-terminal 1 63 1.62 65 6
27 - M c.674G>C p.W225S Missense Forkhead 4 19 0.93 4 4
28 - F c.256delC p.Q86Rfs*106 Frameshift N-terminal 1 132 1.19 60 5
29 - F c.256delC p.Q86Rfs*106 Frameshift N-terminal 1 10 0.92 4 5
30 - F c.479delG p.G160Afs*32 Frameshift N-terminal 1 32 1.06 6 3
31 - M c.688C>T p.Arg230Cys Missense Forkhead 4 24 0.62 3 4
32 - F c.460dupG p.E154Gfs*301 Frameshift N-terminal 1 33 1.12 6 5
33 - M c.136dupC p.Q46Pfs*75 Frameshift N-terminal 1 34 1.06 6 5
34 - M c.566T>C p.L189P Missense Forkhead cs 2 17 1.33 12 5
f = female; m = male; forkhead cs = forkhead conserved site; CSS = clinical severity score (mean), min = 0, max = 2; Agea = Age at last follow
up (months); Age MRI = Age at MRI (months); MRI SS* = MRI severity score, min = 0, max = 8.
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features in specific mutation groups. In comparison with
mutation group 1, there were tendencies to more frequent
occurrence of hypoplasia of the frontal lobes in all other
mutation groups 2 to 5 taken together (p = 0.054), and
especially in patients with forkhead domain conserved site
1 missense variants and forkhead domain except con-
served site 1 frameshift and nonsense variants [mutation
groups 2 (P = 0.060) and 3 (P = 0.067)]. On the other
hand, we found a tendency for more frequent occurrence
of thickening of the fornix in patients from mutation
group 1 compared with all other mutation groups taken
together (P = 0.096). Hypoplasia of basal ganglia, enlarge-
ment of inner CSF spaces and corpus callosum anomalies
were evenly distributed over all five mutation groups.
Phenotype of Foxg1+/ mouse brain
To provide evidence that the structural brain anomalies
observed in our patients are specifically linked to their
FOXG1 variant, we examined telencephalic phenotypes of
adult Foxg1+/ mice.18 As patients with FOXG1 syndrome
display increased propensity toward enlarged fornix, we
focused on the fornix system in our phenotype analysis of
Foxg1+/ mouse brain (Figs. 2 and 3). Coronal sections
from rostral to caudal aspects of the fornix of WT and
Foxg1+/ forebrain were immunostained with antibodies
against MBP and DARPP32 to visualize forebrain struc-
tures like the cortex (Cx), striatum (Str), basal ganglia
(BG), fornix system (F), and corpus callosum (CC).23–26
Overall, heterozygous loss of Foxg1 function resulted in
discernable reduction in forebrain size or volume (Figs. 2
and 3).
Specifically, quantitative analysis revealed significant
reduction in the area and/or thickness of the cortex
(medial, dorsal, lateral), basal ganglia (striatum) and cor-
pus callosum (Fig. 3). Interestingly, the Foxg1+/ mutant
mouse brain also displayed obvious expansion of the fornix
system as compared to that in wild type brain. As shown in
Fig. 2, the observed abnormal enlargement of the fornix is
consistent from the rostral to caudal aspects of the fornix
system in mutant brains. Similarly, all other reported cere-
bral structure alterations were consistent at various coronal
section levels of the Foxg1+/ mouse brain. Thus,
heterozygous loss of Foxg1 function in mouse brain mim-
icked most of the cerebral morphologic anomalies observed
in the brain MRI data set of our FOXG1 syndrome
patients.
Discussion
Standardized evaluation of neuroimaging of 34 patients
with pathogenic or likely pathogenic intragenic FOXG1
variants revealed a characteristic pattern of structural
brain anomalies predominantly affecting the forebrain. In
descending order, we found corpus callosum anomalies,
thickening of the fornix, simplified gyral pattern, enlarge-
ment of inner CSF spaces, hypoplasia of basal ganglia,
and hypoplasia of frontal lobes. While corpus callosum
anomalies, simplified gyral pattern, enlarged ventricles,
and hypoplasia of frontal lobes were described previously
in patients with FOXG1 syndrome,3,8–14 thickening of the
fornix (in 25 out of 34 patients) and, less specifically,
hypoplasia of basal ganglia (in 13 out of 34 patients) have
not been reported before. Fornix thickening is thus a
major highlight in this current investigation.
By employing mouse mutagenesis strategy, we used
heterozygous mutation of the Foxg118 in mouse brain
which reproduced the cardinal structural anomalies
Table 4. Neuroimaging features assorted by the five mutation groups
Feature Mutation group 1 Mutation group 2 Mutation group 3 Mutation group 4 Mutation group 5
n 16 8 3 3 4
FOXG1 clinical severity score
Mean  SD 1.2  0.2 1  0.42 1.1  0.34 1  0.43 0.97  0.4
Median (min; max) 1.2 (0.92; 1.6) 1.1 (0.24; 1.6) 1.2 (0.71; 1.4) 0.93 (0.62; 1.5) 1 (0.47; 1.3)
Simplified gyral pattern, n (%) 13 (81.2) 2 (25.0) 1 (33.3) 2 (66.7) 1 (25.0)
Hypoplasia of frontal lobes, n (%) 2 (12.5) 4 (50.0) 2 (66.7) 1 (33.3) 1 (25.0)
Hypoplasia of basal ganglia, n (%) 8 (50.0) 3 (37.5) 2 (66.7) 0 (0.0) 0 (0.0)
Enlargement of inner CSF spaces, n (%) 9 (56.2) 3 (37.5) 1 (33.3) 0 (0.0) 2 (50.0)
Corpus callosum anomalies
Thinning, n (%) 3 (18.8) 1 (12.5) 1 (33.3) 0 (0.0) 0 (0.0)
Partial agenesis, n (%) 11 (68.8) 5 (62.5) 1 (33.3) 2 (66.7) 3 (75.0)
Complete agenesis, n (%) 1 (6.2) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Thickening of fornices, n (%) 14 (87.5) 5 (62.5) 2 (66.7) 2 (66.7) 2 (50.0)
MRI severity score
Mean  SD 4.6  1.4 3.5  1.8 3.7  3.2 3  1.7 3  2.6
Median (min; max) 5 (1; 7) 4 (0; 5) 5 (0; 6) 4 (1; 4) 3 (0; 6)
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observed in the forebrain of our FOXG1 syndrome
patients. Notably, Foxg1 has been reported to be distinc-
tively expressed in cerebral structures, including the telen-
cephalon.18 Since its first identification as a homologue of
the HNF-3/forkhead gene family,27 Foxg1 has been recog-
nized as a key transcription factor which plays a central,
nonredundant role in mammalian forebrain develop-
ment.28 Together with other transcription factors, it
induces emergence and expansion of the telencephalon
and controls multiple steps of brain circuit formation
comprising cell cycle control and neuronal differentiation
which afford proper brain development.28
For these reasons, it is conceivable that any form of
Foxg1 mutagenesis may result in disturbance of multiple
brain structures and functions as reported in this study.
The observed reduction in the size of cortical and subcor-
tical structures in our mouse mutants is indicative of
microcephaly which is a key feature in FOXG1 syndrome.
Importantly, the reproducibility of fornix expansion
anomaly in our Foxg1+/ mutant mice highlights this
Figure 4. Correlation between clinical severity score and neuroimaging severity score. At the p < 0.05 level there was a significant association
found between clinical severity score and neuroimaging severity score (Kendall’s rank correlation tau: s = 0.27; P = 0.03).
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newly reported phenotype as a potential candidate charac-
teristic for defining the FOXG1 syndrome.
Notably, our statistical analysis revealed a significant
association between pathogenic frameshift and nonsense
variants in the N-terminal domain (mutation group 1) and
simplified gyral pattern on MRI. Furthermore, we found a
significant association between the overall clinical severity
and general degree of structural brain anomalies, with
more severe clinical phenotypes being linked to more pro-
nounced MRI features. At first glance, the latter finding
may seem a matter of course. However, regarding corpus
callosum anomalies as the most frequent feature found in
our cohort, it is well known that even complete agenesis of
the corpus callosum occurs in a wide range of clinical con-
ditions, from incidental finding in an individual with mild
behavioral problems to sole or additional anomaly in
patients with complex and severe neurological impair-
ment.29,30 Thus, the corpus callosum anomaly taken as an
isolated feature does not exclusively account for the serious
clinical phenotype in patients with FOXG1 syndrome.
We showed previously, in a larger cohort of patients with
FOXG1 syndrome, that pathogenic frameshift and non-
sense variants in the N-terminal domain (mutation group
1) are significantly associated with a more severe overall
clinical phenotype.7 We presume that the higher prevalence
of simplified gyral pattern in patients from mutation group
1 will likely explain the significant association between
degree of MRI features and clinical severity.
Fornix
The fornix is a white matter tract bundle constituted mostly
by efferent and afferent fibers between the hippocampi and
structures in the diencephalon and basal forebrain, espe-
cially the basal ganglia. In humans, the fornix consists of
about 1.2 million fibers and is the most distinct hippocam-
pal efferent system.31 Twelve out of the 13 patients with
hypoplasia of the basal ganglia presented with thickened or
expanded fornices. Functionally, abnormal fornices are
known to be associated with episodic memory deficits and
several neurocognitive pertubations.
While involvement of the fornix was observed in a wide
range of acquired conditions including neoplasia, infection,
multiple sclerosis, mesial temporal sclerosis, Wernicke
encephalopathy, trauma, and infarction,32 reports of fornix
anomalies in neurodevelopmental disorders are rare. For
instance, congenital aplasia of the fornix was observed in
holoprosencephaly.33 Also, cross-sectional areas of the for-
nices and mammillary body volumes were found to be
reduced in children with congenital central hypoventilation
syndrome.34
Of note, hyperplastic fornix dorsalis as part of hyper-
plasia of midline structures was disclosed by autopsy of a
physically and intellectually normally developed boy who
had a resection of a lumbar myelomeningocele shortly
after birth and a shunt for.35
Quite recently, a 9-year-old girl presented with moder-
ate intellectual disability, thickening of CC, and hyper-
plastic fornix dorsalis detected by conventional MRI.
Diffusion tensor imaging suggested alterations in fornix
microstructure, attributable to higher fiber density.36
Asymmetrically or symmetrically thickened fornices were
also observed in patients with hemimegalencephaly.37
Aside from these aforementioned reports, we have not
come across any other brain conditions involving predis-
position to thickening or hyperplasia of the fornix struc-
ture as observed in our FOXG1 syndrome patients and
corroborated by the mouse model study.
Since standard neuroimaging does not allow for assess-
ment of the fiber density in the fornices, it is indecisive
that the observed fornix thickening is caused by hyperpla-
sia. Nonetheless, as MRI signal intensities of the thickened
fornices were normal in all patients, we exclude the possi-
bility that the enlargement of the fornix in the brain of
our patients is caused by swelling due to edema.
Simplified gyral pattern
Simplified gyral pattern (SGP) is originally a neuropatho-
logical term designating a reduction in gyrification com-
plexity which is not pachygyria.38 It was reported in a wide
range of genetic conditions, more frequently based on neu-
roimaging than on neuropathological findings. Defined as
“a reduced number of gyri separated by shallow sulci”, it
was first described in FOXG1 syndrome in 2011 in each of
the 11 patients investigated.3 In the study reported here,
standardized qualitative analysis of neuroimaging revealed
SGP in 19 out of 34 patients (56%). This discrepancy may
partially be owing to different subjective thresholds for
denominating an MRI finding as SGP, as, due to the nature
of this feature, strict quantitative criteria for SGP are lack-
ing.
Given that the normal murine cortex is smooth or lis-
sencephalic without recognizable gyrification, it was not
possible to observe or replicate SGP as one of the
reported clinical features seen in FOXG1 syndrome.3
However, although we did not focus on neuron migration
patterns in the Foxg1+/ mouse cortex, it is known that
loss of function of Foxg1 protein disrupts normal migra-
tion of cortical neurons.39–41
Neuronal migration is a crucial neurodevelopmental
process that has been reported, at least in part, to con-
tribute to gyrification of the cortex.42–46 This may partly
provide some basis for the simplified cortical folding phe-
notype or pachygyria observed in the brain of patients with
FOXG1 syndrome. Perhaps, using primates or primate-like
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animal model may be useful in studying the gyral pattern
phenotype associated to Foxg1 mutagenesis.
Corpus callosum
A large number of genes and processes are involved in cal-
losal development, and the genetic causes of CC agenesis
are exceedingly heterogeneous.29,30,47 Development of the
CC may be disturbed by disruption of neurogenesis, telen-
cephalic midline patterning, neuronal migration and speci-
fication, axon guidance, and postguidance development.30
Axonal projections leading to formation of the corpus cal-
losum occur between 11th and 20th week of gestation.48
MRI investigations and mouse model studies provided
conflicting results regarding the temporal sequence of
axonal extension and formation of the four different parts
of the CC: the rostrum, genu, body, and splenium, each
connecting distinct areas of the cortex. However, there is
some evidence that the lamina rostralis (a part of the ros-
trum) and the anterior region of the body are the first
parts of the CC to develop, possibly pioneered by axons
derived from the cingulated cortex and midline glial
structures.48 Callosal axons of the caudal region, later
forming the body of the CC, are in contrast supposed to
follow the axons of the fornix and hippocampal commis-
sure to cross the midline.48
It has been shown in some animal models that mor-
phogenesis of the CC is critically determined by the
proper patterning and establishment of midline telen-
cephalic structures such as the midline zipper glia, glial
wedge, and indusium griseum. These structures essentially
provide guidance for the growth of callosal axons and
prevent their detour to the ventral telencephalon during
their projection trajectory.29
While these data indicate developmental connections
between CC and structures ventral to it like the fornix,
the details of these interactions are not yet understood.
For instance, in agenesis of the CC, the fornices are usu-
ally not malformed.49 It is therefore interesting to observe
enlargement of the fornix system in our patients and ani-
mal model displaying marked callosal hypogenesis conse-
quent to FOXG1 variants.
Conclusion
Based on both, previous observations and the results pre-
sented here, a highly characteristic pattern of neuroimaging
features in FOXG1 syndrome is emerging. The combination
of corpus callosum anomaly with simplified gyral pattern
and hyperplasia of the fornices is possibly pathognomonic
for FOXG1 syndrome. All these three features were present
in 16 (47%) of the 34 patients in this study, any two of
them were found in further nine cases (26%).
Especially the combination of agenesis of the genu cor-
poris callosi with fornix hyperplasia is pointing directly to
FOXG1 syndrome. We therefore suggest that, when agen-
esis or thinning of the anterior parts of the corpus callo-
sum are recognized on midsagittal MRI, the fornices
should be specifically assessed subsequently; if found
thickened, a strong suspicion of FOXG1 syndrome can be
established radiologically.
On the other hand, MRI may exceptionally be com-
pletely normal, as it was in three patients in this study.
Some of the additional MRI features, e.g. enlargement of
inner CSF spaces, are rather unspecific and found in a
wide range of neurodevelopmental disorders.
The characteristic clinical features of FOXG1 syndrome
comprise primary or secondary microcephaly, impairment
of somatic growth, severe global developmental delay,
hyperkinetic-dyskinetic movement disorder, and epilepsy.
This phenotype is characteristic, but not specific, as sev-
eral neurodevelopmental disorders show similar features.
Therefore, currently most FOXG1 variants are being
found using genetic screening tests including array CGH,
multigene panels, or whole exome sequencing. Careful
interpretation of neuroimaging in a child with severe
developmental delay/intellectual disability may reveal the
pattern outlined above and help in evaluation of FOXG1
variants.
Based on clinical reports and animal experimentations,
the predominance of structural brain anomalies in
patients with heterozygous pathogenic FOXG1 variants is
reflective of the essential function of Foxg1 in orchestrat-
ing the normal morphogenesis of the brain. However,
details of the pathogenesis of the particular cerebral mal-
formations described here remain to be determined.
Future perspectives
As far as we know, MR tractography has not yet been per-
formed in patients with FOXG1 syndrome. Such tractogra-
phy studies may help clarifying the structural and
functional consequences of FOXG1 deficiency in forebrain
development. However, as most patients with FOXG1 syn-
drome are severely disabled and definitely need sedation
for MRI, such studies implicate ethical issues if the MR
tractography would be performed as an additional investi-
gation subsequent to standard MRI in the course of patient
care. Likewise, autoptic histo-neuropathological investiga-
tions could further delineate neuroanatomic alterations
associated with deficiency of FOXG1 protein function.
Acknowledgments
We thank all participating families for their kind coopera-
tion. We acknowledge L. Pham for her technical
666 ª 2019 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association.
Structural brain anomalies in FOXG1 syndrome M. Pringsheim et al.
assistance, T. Huttanus and H. Fett for their expert ani-
mal care, J. M. Hebert and S. K. McConnell for providing
Foxg1+/ mouse line. This work was supported by fund-
ing from the Nieders€achsisches Ministerium f€ur Wis-
senschaft und Kultur, grant no. 74ZN1284 (to KB) as
well as by funding from the Research Center Molecular
Physiology of the Brain (CNMPB), Deutsche Forschungs-
gemeinschaft, grant nos. TU432/1-1, TU432/1-3 and the
Schram-Stiftung (to TT).
Conflicts of interest
Nothing to report.
Author contributions
M.P., D.M., G.K., M.S. and K.B. contributed to concep-
tion and design of the study; M.P., D.M., S.S., R.W., K.P.,
G.K., M.B., T.B., S.B., H.M.B., E.C., C.C., A.N.D., A.E.,
T.A.G., A.H-W., M.H., K.H., A.M.K., S.K., T.K., G.C.K.,
B.K., R.E.L., H.O., S.P., H.P., K.R., T.R., A.R., M.S., R.W.,
F.M.Z., B.Z., P.A.U., G.S., T.T., A.L., M.S. and K.B. con-
tributed to acquisition and analysis of data; S.S., P.A.U.,
G.S., T.T., A.L., M.S. and K.B. contributed to drafting the
text and preparing the figures. M.P. and D.M. as well as
M.S. and K.B. contributed equally to this work.
References
1. Ariani F, Hayek G, Rondinella D, et al. FOXG1 is
responsible for the congenital variant of Rett syndrome.
Am J Hum Genet 2008;83(1):89–93.
2. Mencarelli MA, Kleefstra T, Katzaki E, et al. 14q12
Microdeletion syndrome and congenital variant of Rett
syndrome. Eur J Med Genet 2009;52:148–152.
3. Kort€um F, Das S, Flindt M, et al. The core FOXG1
syndrome phenotype consists of postnatal microcephaly,
severe mental retardation, absent language, dyskinesia, and
corpus callosum hypogenesis. J Med Genet 2011;48:396–
406.
4. Philippe C, Amsallem D, Francannet C, et al. Phenotypic
variability in Rett syndrome associated with FOXG1
mutations in females. J Med Genet 2010;47:59–65.
5. De Filippis R, Pancrazi L, Bjørgo K, et al. Expanding the
phenotype associated with FOXG1 mutations and in vivo
FoxG1 chromatin-binding dynamics. Clin Genet 2012;82
(4):395–403.
6. Cellini E, Vignoli A, Pisano T, et al. The hyperkinetic
movement disorder of FOXG1-related epileptic-dyskinetic
encephalopathy. Dev Med Child Neurol 2016;58(1):93–
97.
7. Mitter D, Pringsheim M, Kaulisch M, et al. FOXG1
syndrome: Genotype-phenotype association in 83 patients
with FOXG1 variants. Genet Med 2018;20:98–108.
8. Caporali C, Signorini S, De Giorgis V, et al. Early-onset
movement disorder as diagnostic marker in genetic
syndromes: Three cases of FOXG1-related syndrome. Eur J
Paediatr Neurol 2018;22:336–339.
9. Bahi-Buisson N, Nectoux J, Girard B, et al. Revisiting the
phenotype associated with FOXG1 mutations: Two novel
cases of congenital Rett variant. Neurogenetics
2010;11:241–249.
10. Le Guen T, Fichou Y, Nectoux J, et al. A missense
mutation within the fork-head domain of the forkhead
box G1 Gene (FOXG1) affects its nuclear localization.
Hum Mutat 2011;32(2):35.
11. Mencarelli MA, Spanhol-Rosseto A, Artuso R, et al. Novel
FOXG1 mutations associated with the congenital variant
of Rett syndrome. J Med Genet 2010;47:49–53.
12. Takahashi S, Matsumoto N, Okayama A, et al. FOXG1
mutations in Japanese patients with the congenital variant
of Rett syndrome. Clin Genet 2012;82(6):569–573.
13. De Bruyn C, Vanderhasselt T, Tanyalcin I, et al. Thin genu of
the corpus callosum points to mutation in FOXG1 in a child
with acquired microcephaly, trigonocephaly, and intellectual
developmental disorder: A case report and review of
literature. Eur J Paediatr Neurol 2014;18(3):420–426.
14. McMahon KQ, Papandreou A, Ma M, et al. Familial
recurrences of FOXG1-related disorder: Evidence for
mosaicism. Am J Med Genet A 2015;167(12):3096–3102.
15. Eagleson KL, Schlueter McFadyen-Ketchum LJ, Ahrens ET,
et al. Disruption of Foxg1 expression by knock-in of cre
recombinase: Effects on the development of the mouse
telencephalon. Neuroscience 2007;148:385–399.
16. Brockmann K. Acquisition of Rare Neurological Disorders
in Childhood (Erhebung Seltener Neurologischer
Erkrankungen im Kindesalter—ESNEK). Neuropediatrics
2014;45 - fp036.
17. Richards S, Aziz N, Bale S, et al. Standards and guidelines
for the interpretation of sequence variants: A joint
consensus recommendation of the American College of
Medical Genetics and Genomics and the Association for
Molecular Pathology. Genet Med 2015;17(5):405–424.
18. Hebert JM, McConnell SK. Targeting of cre to the Foxg1
(BF-1) locus mediates loxP recombination in the
telencephalon and other developing head structures. Dev
Biol 2000;222:296–306.
19. Narayanan R, Pirouz M, Kerimoglu C, et al. Loss of BAF
(mSWI/SNF) Complexes Causes Global Transcriptional
and Chromatin State Changes in Forebrain Development.
Cell Rep 2015;13:1842–1854.
20. Nguyen H, Kerimoglu C, Pirouz M, et al. Epigenetic
Regulation by BAF Complexes Limits Neural Stem Cell
Proliferation by SuppressingWnt Signaling in Late
Embryonic Development. Stem Cell Rep 2018;10:1734–1750.
21. Tuoc TC, Boretius S, Sansom SN, et al. Chromatin
Regulation by BAF170 Controls Cerebral Cortical Size and
Thickness. Dev Cell 2013;25:256–269.
ª 2019 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association. 667
M. Pringsheim et al. Structural brain anomalies in FOXG1 syndrome
22. Narayanan R, Pham L, Kerimoglu C, et al. Chromatin
Remodeling BAF155 Subunit Regulates the Genesis of
Basal Progenitors in Developing Cortex. iScience
2018;4:109–126.
23. Gow A, Friedrich VL Jr, Lazzarini RA. Myelin basic
protein gene contains separate enhancers for
oligodendrocyte and Schwann cell expression. J Cell Biol
1992;119:605–616.
24. Calamante F, Tournier JD, Kurniawan ND, et al.
Super-resolution track-density imaging studies of mouse
brain: Comparison to histology. NeuroImage
2012;59:286–296.
25. Zhou YX, Pannu R, Le TQ, Armstrong RC. Fibroblast
growth factor 1 (FGFR1) modulation regulates repair
capacity of oligodendrocyte progenitor cells following
chronic demyelination. Neurobiol Dis 2012;45:196–205.
26. Lee KM, Bang JH, Han JS, et al. Cardiotonic pill
attenuates white matter and hippocampal damage via
inhibiting microglial activation and downregulating ERK
and p38 MAPK signaling in chronic cerebral hypoperfused
rat. BMC Complement Altern Med 2013;13:334.
27. Tao W, Lai E. Telencephalon-restricted expression of BF-1,
a new member of the HNF-3/fork head gene family, in the
developing rat brain. Neuron 1992;8:957–966.
28. Kumamoto T, Hanashima C. Evolutionary conservation
and conversion of Foxg1 function in brain development.
Dev Growth Differ 2017;59:258–269.
29. Paul LK, Brown WS, Adolphs R, et al. Agenesis of the
corpus callosum: Genetic, developmental and functional
aspects of connectivity. Nat Rev Neurosci 2007;8:287–299.
30. Edwards TJ, Sherr EH, Barkovich AJ, Richards LJ. Clinical,
genetic and imaging findings identify new causes for
corpus callosum development syndromes. Brain
2014;137:1579–1613.
31. Ten Donkelaar HJ. Clinical Neuroanatomy. Brain Circuitry
and Its Disorders. Berlin, Heidelberg: Springer, 2011.
32. Thomas AG, Koumellis P, Dineen RA. The fornix in
health and disease: An imaging review. Radiographics
2011;31:1107–1121.
33. Takahashi T, Kinsman S, Makris N, et al. Semilobar
holoprosencephaly with midline ‘seam’: A topologic and
morphogenetic model based upon MRI analysis. Cereb
Cortex 2003;13:1299–1312.
34. Kumar R, Lee K, Macey PM, et al. Mammillary body and
fornix injury in congenital central hypoventilation
syndrome. Pediatr Res 2009;66:429–434.
35. Friede RL, Briner J. Midline hyperplasia with
malformation of the fornical system. Neurology
1978;28:1302–1305.
36. Contarino VE, Bulgheroni S, Savoiardo M, et al.
Constrained spherical deconvolution-based tractography to
depict and characterize a case of “hyperplastic fornix
dorsalis”. Magn Reson Imaging 2014;32:1428–1433.
37. Sato N, Ota M, Yagishita A, et al. Aberrant midsagittal
fiber tracts in patients with hemimegalencephaly. AJNR
Am J Neuroradiol 2008;29:823–827.
38. Peiffer A, Singh N, Leppert M, et al. Microcephaly with
simplified gyral pattern in six related children. Am J Med
Genet 1999;84:137–144.
39. Miyoshi G, Fishell G. Dynamic FoxG1 expression
coordinates the integration of multipolar pyramidal
neuron precursors into the cortical plate. Neuron
2012;74:1045–1058.
40. Baek ST, Copeland B, Yun EJ, et al. An AKT3-FOXG1-
reelin network underlies defective migration in human
focal malformations of cortical development. Nat Med
2015;21:1445–1454.
41. Yang Y, Shen W, Ni Y, et al. Impaired Interneuron
Development after Foxg1 Disruption. Cereb Cortex
2017;27:793–808.
42. Gertz CC, Kriegstein AR. Neuronal Migration Dynamics in
the Developing Ferret Cortex. J Neurosci 2015;35:14307–
14315.
43. Nowakowski TJ, Pollen AA, Sandoval-Espinosa C,
Kriegstein AR. Transformation of the Radial Glia Scaffold
Demarcates Two Stages of Human Cerebral Cortex
Development. Neuron 2016;91:1219–1227.
44. De Juan Romero C, Borrell V. Genetic maps and patterns of
cerebral cortex folding. Curr Opin Cell Biol 2017;49:31–37.
45. Del Toro D, Ruff T, Cederfjall E, et al. Regulation of
Cerebral Cortex Folding by Controlling Neuronal
Migration via FLRT Adhesion Molecules. Cell
2017;169:621–635.
46. Shinmyo Y, Terashita Y, Dinh Duong TA, et al. Folding of
the Cerebral Cortex Requires Cdk5 in Upper-Layer
Neurons in Gyrencephalic Mammals. Cell Rep
2017;20:2131–2143.
47. Dobyns WB. Absence makes the search grow longer. Am J
Hum Genet 1996;58:7–16.
48. Kamnasaran D. Corpus callosum: Agenesis. In: Squire LR,
ed. Encyclopedia of Neuroscience. Amsterdam: Elsevier,
2009:163–173.
49. Friede RL. Developmental Neuropathology, 2nd ed. Berlin,
New York: Springer, 1989.
Supporting Information
Additional supporting information may be found online
in the Supporting Information section at the end of the
article.
Table S1. Quantitative histological data of various cere-
bral structures in Foxg1+/ mouse model vs. wildtype
(WT).
Table S2. Clinical, genetic and neuroimaging features in
patients with FOXG1 syndrome.
668 ª 2019 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association.
Structural brain anomalies in FOXG1 syndrome M. Pringsheim et al.
